iXgene
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $4.5M
Investors
- 1
About iXgene
Based in Tokyo, Japan, and founded in 2020 iXgene Inc. provides treatment for intractable brain diseases. In January 2023, iXgene Inc. As of 2023, the company is headed by its CEO Toshiharu Furukawa who founded the company along with Atsushi Mizuno. The company develops therapeutic drugs for brain disease treatment such as the recurrence treatment of brain tumors and functional recovery from brain injury. The firm does the treatment using suicidal gene-introduced iPS cell-derived neural stem cells technology.
Who invested in iXgene
1 investor across 1 round
See all investors in iXgene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2023
Amount
$4.5M
Investors
Questions about iXgene
Who invested in iXgene?
iXgene has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iXgene raised?
iXgene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iXgene last raise money?
iXgene's most recent round on record is a Series A, in Jan 2023.
What does iXgene do?
Based in Tokyo, Japan, and founded in 2020 iXgene Inc.
Where is iXgene headquartered?
iXgene is headquartered in Tokyo, Japan.
Which VCs invest in companies like iXgene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at iXgene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iXgene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.